Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (4): 629-633    DOI: 10.31083/j.ejgo.2020.04.5395
Case Report Previous articles | Next articles
Successful treatment of uterine cervical carcinoma with extensive vaginal lesions using laparoscopic surgery: A case report
Hiroshi Yoshida1, 3, Megumi Yamamoto2, 3, *(), Hiroyuki Shigeta3
1Department of Obstetrics and Gynecology, Tokai University School of Medicine, Shimokasuya 143 Ishehara, Kanagawa, Japan
2Department of Obstetrics and Gynecology, Fukui Prefectural Hospital, Yotsui 2-8-1 Fukui City, Fukui, Japan
3Department of Obstetrics and Gynecology, Yokohama Municipal Citizen's Hospital, 56 Okazawa, Hodogaya-ku, Yokohama City, Kanagawa, Japan
Download:  PDF(776KB)  ( 218 ) Full text   ( 7 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objective: To present a rare case of uterine cervical carcinoma of 2008 International Federation of Gynecology and Obstetrics (FIGO) stage IB1 (pT2bN0M0), with extensive vaginal lesions treated by minimally invasive surgery. Case report: The vaginal mucosa of the patient was affected by intraepithelial carcinoma with focal invasion at almost the entire area. The whole lesions were completely removed by total laparoscopic radical hysterectomy and complete vaginectomy. Conclusions: The technique described in this report appears to be safe and feasible, and may be a useful option for the treatment of similar cases.
Key words:  Cervical cancer      Minimally invasive surgery      Vaginal intraepithelial carcinoma     
Submitted:  07 October 2019      Accepted:  31 March 2020      Published:  15 August 2020     
*Corresponding Author(s):  MEGUMI YAMAMOTO     E-mail:  qwers.m.y@gmail.com

Cite this article: 

Hiroshi Yoshida, Megumi Yamamoto, Hiroyuki Shigeta. Successful treatment of uterine cervical carcinoma with extensive vaginal lesions using laparoscopic surgery: A case report. European Journal of Gynaecological Oncology, 2020, 41(4): 629-633.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.04.5395     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I4/629

[1] Yi-fan Luo, Li-xiang Ren, Ming-yan Jiang, Yang Chu. A systematic review and meta-analysis on the effects of metformin on survival outcomes and risk in women with cervical cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 504-507.
[2] Liman Yang, Jing Jin, Juhong Liu. Correlation of MMP2-C1306T (rs243865) and MMP7-181A/G (rs11568818) with cervical cancer: a meta-analysis[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 508-512.
[3] Panteleimon Mnimatidis, Abraham Pouliakis, George Valasoulis, George Michail, Aris Spathis, Christine Cottaridi, Niki Margari, Maria Kyrgiou, Maria Nasioutziki, Alexandros Daponte, Konstantinos Dinas, Evangelos Paraskevaidis, Ioannis Panayiotides, Dimitrios-Dionysios Koutsouris. Multicentric assessment of cervical HPV infection co-factors in a large cohort of Greek women[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 545-555.
[4] Fengmei Wang , Huachun Luo , Huihua Cheng, Huijuan Huang , Zhichao Fu. Is 3D printing-gided three-dimensional brachytherapy suitable for cervical cancer: from one single research institute?[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 591-597.
[5] Hikari Unno, Seiji Mabuchi, Isao Arai, Tomoko Wakasa, Seiichi Yamamasu. Development of lymphangiosarcoma after pelvic radiation therapy for uterine cervical cancer: A case report and literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 326-331.
[6] L. Xu, H. Cai, N. Zhu, Bo Zheng. Interleukin-22 derived from cervical cancer-associated fibroblasts accelerates senescence of normal fibroblasts and promotes expression of tumorigenesis-related factors in HeLa cells[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 192-199.
[7] Hong Yan, Chunhua Zhang, Tingting Liu, Jianzhong Liu. Mifepristone regulates the multidrug resistance via miR-758/MEPE of Hela cell lines[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 214-220.
[8] K. Plagens–Rotman, M. Piskorz–Szymendera, B. PIĘTA. Lifestyle with particular emphasis on physical activity and genital carcinomas in women[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 233-239.
[9] B. Bárány, R. Póka. Nutritional assessment among patients with cervical cancer and controls[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 23-29.
[10] D. Kim, Y. Ki, W. Kim, D. Park, D. Suh, K. Kim, J. Lee, H. Jeon, J. Nam. Positive pelvic lymph node on [18F]-FDG PET is a prognostic factor in early-stage high-risk cervical cancer treated by radical hysterectomy and adjuvant chemoradiotherapy[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 42-47.
[11] H. Imafuku, Y. Ebina, K. Suzuki, S. Wakahashi, Y. Miyahara, K. Yoshida, H. Yamada. Definitive radiotherapy in elderly patients and patients with locally advanced cervical cancer with complications[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 60-64.
[12] Y. Murata, Y. Miyahara, K. Suzuki, S. Wakahashi, T. Sudo, S. Nagao, S. Yamaguchi, Y. Ebina, H. Yamada. Leukocytosis and thrombocytosis as prognostic factors for women with uterine cervical cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 93-97.
[13] N. Habib, T. Dennis, G. Centini, L. Bresson, F. Narducci, E. Leblanc. Glassy cell carcinoma: is surgical treatment with preservation of the uterus a therapeutic option?[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 121-125.
[14] R. Tasaka, Y. Hashiguchi, M. Kasai, T. Fukuda, T. Ichimura, T. Yasui, T. Sumi. Secondary small cell carcinoma of the endometrium after concurrent chemoradiotherapy for cervical cancer: a rare case[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 142-144.
[15] T. Tantitamit, K.-G. Huang, A. Temtanakitpaisan. Emerging role of sentinel lymph node mapping for gynecologic oncology in the new era[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 905-914.
No Suggested Reading articles found!